7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Barrett’s oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review

      review-article
      , , , ,
      BJS Open
      Oxford University Press

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Concern exists that patients born with oesophageal atresia (OA) may be at high risk for Barrett’s oesophagus (BO), a known malignant precursor to the development of oesophageal adenocarcinoma. Screening endoscopy has a role in early BO identification but is not universal in this population. This study aimed to determine prevalence of BO after OA repair surgery, to quantify the magnitude of this association and inform the need for screening and surveillance.

          Methods

          A systematic review, undertaken according to PRISMA guidelines, was preregistered on PROSPERO (CRD42017081001). PubMed and EMBASE were interrogated using a standardized search strategy on 31 July 2020. Included papers, published in English, reported either: one or more patients with either BO (gastric/intestinal metaplasia) or oesophageal cancer in patients born with OA; or long-term (greater than 2 years) follow-up after OA surgery with or without endoscopic screening or surveillance.

          Results

          Some 134 studies were identified, including 19 case reports or series and 115 single- or multi-centre cohort studies. There were 13 cases of oesophageal cancer (9 squamous cell carcinoma, 4 adenocarcinoma) with a mean age at diagnosis of 40.5 (range 20–47) years. From 6282 patients under long-term follow-up, 317 patients with BO were reported. Overall prevalence of BO was 5.0 (95 per cent c.i. 4.5 to 5.6) per cent, with a mean age at detection of 13.8 years (range 8 months to 56 years). Prevalence of BO in series reporting endoscopic screening or surveillance was 12.8 (95 per cent c.i. 11.3 to 14.5) per cent.

          Conclusion

          Despite a limited number of cancers, the prevalence of BO in patients born with OA is relatively high. While limited by the quality of available evidence, this review suggests endoscopic screening and surveillance may be warranted, but uncertainties remain over the design and effectiveness of any putative programme.

          Abstract

          There are concerns that patients born with oesophageal atresia are at high risk for Barrett’s oesophagus, a known malignant precursor. This systematic review aimed to determine the prevalence of Barrett's oesophagus in patients born with oesophageal atresia under long-term follow-up to quantify the magnitude of the association and inform the need for screening. The prevalence of Barrett’s oesophagus is relatively high in this population, at 5 per cent, and suggests endoscopic screening may be warranted.

          Related collections

          Most cited references90

          • Record: found
          • Abstract: found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

          David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Rayyan—a web and mobile app for systematic reviews

            Background Synthesis of multiple randomized controlled trials (RCTs) in a systematic review can summarize the effects of individual outcomes and provide numerical answers about the effectiveness of interventions. Filtering of searches is time consuming, and no single method fulfills the principal requirements of speed with accuracy. Automation of systematic reviews is driven by a necessity to expedite the availability of current best evidence for policy and clinical decision-making. We developed Rayyan (http://rayyan.qcri.org), a free web and mobile app, that helps expedite the initial screening of abstracts and titles using a process of semi-automation while incorporating a high level of usability. For the beta testing phase, we used two published Cochrane reviews in which included studies had been selected manually. Their searches, with 1030 records and 273 records, were uploaded to Rayyan. Different features of Rayyan were tested using these two reviews. We also conducted a survey of Rayyan’s users and collected feedback through a built-in feature. Results Pilot testing of Rayyan focused on usability, accuracy against manual methods, and the added value of the prediction feature. The “taster” review (273 records) allowed a quick overview of Rayyan for early comments on usability. The second review (1030 records) required several iterations to identify the previously identified 11 trials. The “suggestions” and “hints,” based on the “prediction model,” appeared as testing progressed beyond five included studies. Post rollout user experiences and a reflexive response by the developers enabled real-time modifications and improvements. The survey respondents reported 40% average time savings when using Rayyan compared to others tools, with 34% of the respondents reporting more than 50% time savings. In addition, around 75% of the respondents mentioned that screening and labeling studies as well as collaborating on reviews to be the two most important features of Rayyan. As of November 2016, Rayyan users exceed 2000 from over 60 countries conducting hundreds of reviews totaling more than 1.6M citations. Feedback from users, obtained mostly through the app web site and a recent survey, has highlighted the ease in exploration of searches, the time saved, and simplicity in sharing and comparing include-exclude decisions. The strongest features of the app, identified and reported in user feedback, were its ability to help in screening and collaboration as well as the time savings it affords to users. Conclusions Rayyan is responsive and intuitive in use with significant potential to lighten the load of reviewers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

              Barrett's esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best practices in caring for these patients. These guidelines continue to endorse screening of high-risk patients for BE; however, routine screening is limited to men with reflux symptoms and multiple other risk factors. Acknowledging recent data on the low risk of malignant progression in patients with nondysplastic BE, endoscopic surveillance intervals are attenuated in this population; patients with nondysplastic BE should undergo endoscopic surveillance no more frequently than every 3-5 years. Neither routine use of biomarker panels nor advanced endoscopic imaging techniques (beyond high-definition endoscopy) is recommended at this time. Endoscopic ablative therapy is recommended for patients with BE and high-grade dysplasia, as well as T1a esophageal adenocarcinoma. Based on recent level 1 evidence, endoscopic ablative therapy is also recommended for patients with BE and low-grade dysplasia, although endoscopic surveillance continues to be an acceptable alternative. Given the relatively common recurrence of BE after ablation, we suggest postablation endoscopic surveillance intervals. Although many of the recommendations provided are based on weak evidence or expert opinion, this document provides a pragmatic framework for the care of the patient with BE.
                Bookmark

                Author and article information

                Contributors
                Journal
                BJS Open
                BJS Open
                bjsopen
                BJS Open
                Oxford University Press
                2474-9842
                July 2021
                05 August 2021
                05 August 2021
                : 5
                : 4
                : zrab069
                Affiliations
                Department of Paediatric Surgery and Urology, Southampton Children’s Hospital , Southampton, UK
                National Institute for Health Research Great Ormond Street Hospital Biomedical Research Centre, University College London Great Ormond Street Institute for Child Health , London, UK
                Stem Cell and Cancer Biology Laboratory, The Francis Crick Institute , London, UK
                Department of Paediatric Surgery and Urology, Southampton Children’s Hospital , Southampton, UK
                Department of Paediatric Surgery and Urology, Southampton Children’s Hospital , Southampton, UK
                University Surgery Unit, Faculty of Medicine, University of Southampton , Southampton, UK
                Department of Paediatric Surgery and Urology, Southampton Children’s Hospital , Southampton, UK
                Department of Paediatric Surgery and Urology, Southampton Children’s Hospital , Southampton, UK
                University Surgery Unit, Faculty of Medicine, University of Southampton , Southampton, UK
                Author notes
                Correspondence to: (L.T.) Department of Paediatric Surgery and Urology, Southampton Children’s Hospital, Tremona Road, Southampton SO16 6YD, UK (e-mail: ltullie@ 123456doctors.org.uk ); (N.J.H.) University Surgery Unit, Faculty of Medicine,University of Southampton, Tremona Road, Southampton SO16 6YD, UK (e-mail: n.j.hall@ 123456soton.ac.uk )
                Author information
                https://orcid.org/0000-0001-5679-7504
                https://orcid.org/0000-0001-8570-9374
                Article
                zrab069
                10.1093/bjsopen/zrab069
                8405903
                34370830
                d739f79e-8fd0-4c47-9795-afa728f34734
                © The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 April 2021
                : 17 June 2021
                Page count
                Pages: 10
                Funding
                Funded by: NIHR Great Ormond Street Hospital Biomedical Research Centre and G.B.;
                Funded by: NIHR Academic Clinical;
                Categories
                Systematic Review
                AcademicSubjects/MED00010
                AcademicSubjects/MED00910

                Comments

                Comment on this article